CBA PHARMA INC has a total of 33 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, environmental technology and foods and drinks are BCN BIOSCIENCES L L C, ULTUPHARMA AB and ANKH LIFE SCIENCES LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | China | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Republic of Korea | 4 | |
#6 | Mexico | 4 | |
#7 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Foods and drinks | |
#4 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Carroll Ron D | 15 |
#2 | Barnett Daryl L | 12 |
#3 | Gudeman Beth D | 3 |
#4 | Mitchell James A | 2 |
#5 | Murty Ram | 1 |
#6 | Van Dyke Knox | 1 |
#7 | Putnam Wayne Michael | 1 |
Publication | Filing date | Title |
---|---|---|
US2015073151A1 | Supercritical fluid extraction of bis-benzyl isoquinolines | |
WO2014150996A1 | Cancer treatment | |
WO2014150959A2 | Method and products for enhancing cellular uptake of drug and dietary supplements | |
KR20150143504A | Method and products for enhancing drug and dietary supplement bioavailability | |
US2014275138A1 | Method and products for treating diabetes | |
KR20150142691A | Tetrandrine family pharmaceutical formulations and method | |
MX2015003329A | Tetrandrine pharmaceutical formulations and method. | |
WO2014043347A1 | Mdr method and products for treating mrsa |